EnCoRe MoMS:Engaging Communities to Reduce Morbidity From Maternal Sepsis
NCT ID: NCT06160349
Last Updated: 2024-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
200 participants
OBSERVATIONAL
2023-07-20
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the UG3 phase, robust community engagement and research infrastructures were established to: 3a. (3a.1) Refine the CoLAB and co-design process; (3a.2) Conduct in-depth individual patient interviews (IDIs) and focus group discussions (FGDs) with community and hospital stakeholders from one site to explore the lived experiences and perspectives of SDOH on care access/quality, outcome disparities, and solutions for care continuity.
In the UH3 phase, the investigators will engage the community toAim 3b. (3b.1) Complete qualitative patient IDIs and stakeholder FGDs for the three additional hospital sites; (3b.2) Co-design an integrative supportive care model, with our community partner co-lead, CoLAB, and results from other aims, that entails maternal sepsis community engagement, care linkages, education, services, and policy efforts. The resulting model can be scaled to hospitals and communities with lesser resources and applied to other preventable causes of severe maternal morbidity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient Interviews
Patients with risk factors for maternal sepsis interviewed about pregnancy, labor/delivery, and postpartum via Zoom.
No interventions assigned to this group
Community Stakeholders
Community stakeholders with professional and/or academic backgrounds relevant to maternal health who participate in focus group discussion.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Speak Spanish or English
* Be 18 years or older
* Have a birthing experience in Columbia, Allen, Lincoln, or Harlem Hospitals within the past 8 weeks of enrollment
* Have had at least one early warning sign or risk factor for infection present during their pregnancy, delivery, or postpartum
Community Stakeholder Focus Groups:
* Speak English or Spanish
* Be 18 years or older
* Have academic/professional background relevant to maternal health in New York City.
Exclusion Criteria
* Under 18 years old
* Speaks a language other than Spanish or English
* Gave birth in a hospital other than Columbia, Allen, Lincoln, or Harlem Hospitals
* Did not have had at least one early warning sign or risk factor for infection present during their pregnancy, delivery, or postpartum
Community Stakeholder Focus Groups
* Under 18 years old
* Speaks a language other than Spanish or English
* Does not have a academic/professional background relevant to maternal health in New York City.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northern Manhattan Perinatal Partnership
OTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Uma Reddy
Professor of Obstetrics and Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Uma Reddy, MD
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Columbia Unviersity Medical Center
New York, New York, United States
NYC Health+Hospitals/Harlem
New York, New York, United States
NYC Health + Hospitals/Lincoln
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAU3697 - Aim 3
Identifier Type: -
Identifier Source: org_study_id